A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Randomised Controlled Trial, Of N-Acetyl Cysteine (NAC), for Premanifest Huntingtin Gene Expansion Carriers	Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyskinesias, Huntington disease, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder	Recruiting	Phase 2	2025-02-28		NCT05509153

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Deakin University	16
Monash University	75
Royal Perth Hospital	4
The University of Queensland	41
University of Melbourne	71
Western Sydney Local Health District	24

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Calvary Health Care Bethlehem	Parkdale	Australia	1
Perron Institute	Nedlands	Australia	4
The Royal Melbourne Hospital	Parkville	Australia	26
The University of Queensland	Herston	Australia	1
Westmead Hospital	Westmead	Australia	128